ikcs 2020 session 4: metabolism as a target for rcc
Published 3 years ago • 15 plays • Length 40:27Download video MP4
Download video MP3
Similar videos
-
1:01:19
ikcs 2020: session 1: multimodality therapy for locally advanced rcc
-
50:08
ikcs 2020: non-clear cell rcc session
-
2:09:09
ikcs 2020: session 5: multimodality therapy for metastatic rcc
-
1:33:22
ikcs 2020: session 3 immunotherapy and emerging therapies for rcc
-
11:53
ikcs 2020: metabolic gene signature as biomarker for recurrence in localized clear cell rcc
-
10:55
ikcs 2020: phase 2 trial of lenvatinib at 2 starting doses everolimus in renal cell carcinoma (rcc)
-
1:02:20
#kcrs20: new molecular targets for kidney cancer
-
1:10:11
ikcs 2020 top abstracts session
-
1:05:56
the genetic basis of kidney cancer: targeting the metabolic basis of disease
-
1:11:21
kcrs22 session three: rapid abstract presentations at the kidney cancer research summit
-
6:48
kidney cancer: treatment for stage 4 (metastatic)
-
1:10:39
targeting the genetic basis of kidney cancer: a metabolic disease - w. marston linehan
-
4:49
frontline tki strategies in kidney cancer
-
16:58
urogripp: epidemiology, etiology and histological variants of renal cancer - dr. ashwin tamhankar
-
24:53
systemic treatment options for patients with metastatic non-clear cell renal cell carcinoma
-
12:48
checkmate 214: 4-year follow-up and subgroup analysis of patients without nephrectomy
-
12:16
non clear-cell type rcc
-
6:21
kidney cancer is a metabolic disease — w. marston linehan, nih: part 1